| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Ambulatory administration of 5-day infusion ifosfamide + mesna: a pilot study in sarcoma patients
|
Coriat, Romain
|
|
2009
|
65 |
3 |
p. 491-495
|
artikel
|
| 2 |
A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer
|
Oh, Do-Youn
|
|
2009
|
65 |
3 |
p. 527-536
|
artikel
|
| 3 |
A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer
|
Dent, Susan F.
|
|
2009
|
65 |
3 |
p. 557-561
|
artikel
|
| 4 |
A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer
|
Sharma, Atul
|
|
2009
|
65 |
3 |
p. 497-502
|
artikel
|
| 5 |
A phase II study of oxaliplatin, docetaxel, and GM-CSF in patients with previously treated advanced melanoma
|
Locke, Frederick
|
|
2009
|
65 |
3 |
p. 509-514
|
artikel
|
| 6 |
Effect of rifampin on the pharmacokinetics of Axitinib (AG-013736) in Japanese and Caucasian healthy volunteers
|
Pithavala, Y. K.
|
|
2009
|
65 |
3 |
p. 563-570
|
artikel
|
| 7 |
Effects of bevacizumab on plasma concentration of irinotecan and its metabolites in advanced colorectal cancer patients receiving FOLFIRI with bevacizumab as second-line chemotherapy
|
Horita, Yosuke
|
|
2009
|
65 |
3 |
p. 467-471
|
artikel
|
| 8 |
Effects of cyclooxygenase inhibitor treatment on the renal toxicity of cisplatin in rats
|
Greene, Shawna N.
|
|
2009
|
65 |
3 |
p. 549-556
|
artikel
|
| 9 |
Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma
|
Galvão, Flávio Henrique Ferreira
|
|
2009
|
65 |
3 |
p. 607-610
|
artikel
|
| 10 |
Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins
|
Işeri, Özlem Darcansoy
|
|
2009
|
65 |
3 |
p. 447-455
|
artikel
|
| 11 |
Inclusion complexes of noscapine in β-cyclodextrin offer better solubility and improved pharmacokinetics
|
Madan, Jitender
|
|
2009
|
65 |
3 |
p. 537-548
|
artikel
|
| 12 |
Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOP
|
Chae, Yee Soo
|
|
2009
|
65 |
3 |
p. 571-577
|
artikel
|
| 13 |
MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer
|
Sun, Ning
|
|
2009
|
65 |
3 |
p. 437-446
|
artikel
|
| 14 |
Multicenter phase 2 study of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma
|
Kurita, Hiroshi
|
|
2009
|
65 |
3 |
p. 503-508
|
artikel
|
| 15 |
Pharmacokinetic interaction between tamoxifen and ondansetron in rats: non-competitive (hepatic) and competitive (intestinal) inhibition of tamoxifen metabolism by ondansetron via CYP2D subfamily and 3A1/2
|
Yang, Si Hyung
|
|
2009
|
65 |
3 |
p. 407-418
|
artikel
|
| 16 |
Pharmacokinetics and tissue distribution of PGG–paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenografts
|
Wang, Xinghe
|
|
2009
|
65 |
3 |
p. 515-526
|
artikel
|
| 17 |
Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer
|
Pourgholami, Mohammad H.
|
|
2009
|
65 |
3 |
p. 597-605
|
artikel
|
| 18 |
Phase I/II and pharmacokinetic study of S-1 and oxaliplatin in previously untreated advanced gastric cancer
|
Park, Inkeun
|
|
2009
|
65 |
3 |
p. 473-480
|
artikel
|
| 19 |
Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer
|
Bae, Woo Kyun
|
|
2009
|
65 |
3 |
p. 589-595
|
artikel
|
| 20 |
Plasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primates
|
Muscal, Jodi A.
|
|
2009
|
65 |
3 |
p. 419-425
|
artikel
|
| 21 |
Predictive factors for the efficacy of cetuximab plus chemotherapy as salvage therapy in metastatic gastric cancer patients
|
Park, Sook Ryun
|
|
2009
|
65 |
3 |
p. 579-587
|
artikel
|
| 22 |
Protein kinase inhibitors emodin and dichloro-ribofuranosylbenzimidazole modulate the cellular accumulation and cytotoxicity of cisplatin in a schedule-dependent manner
|
Kurokawa, Tetsuji
|
|
2009
|
65 |
3 |
p. 427-436
|
artikel
|
| 23 |
Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer
|
Nieto, Yago
|
|
2009
|
65 |
3 |
p. 457-465
|
artikel
|
| 24 |
Synergistic effect of 5-fluorouracil and the flavanoid oroxylin A on HepG2 human hepatocellular carcinoma and on H22 transplanted mice
|
Zhao, Li
|
|
2009
|
65 |
3 |
p. 481-489
|
artikel
|
Tijdschrift beschrijving